AQST FY 2023 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$51M+6.1% YoY

Gross Profit

$30M58.8% margin

Operating Income

-$15M-29.9% margin

Net Income

-$8M-15.6% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$57M

Total Liabilities

$164M

Stockholders' Equity

-$106M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$48M	+6.1%
Gross Profit	$30M	$28M	+5.2%
Operating Income	-$15M	-$42M	+64.1%
Net Income	-$8M	-$54M	+85.5%